Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET	digestive system neuroendocrine neoplasm	Active, not recruiting	Phase 3	2026-07-28		NCT05050942
Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Recruiting	Not stated	2026-01-09		NCT07240662

Clinical trials